Total cholesterol and cancer risk in a large prospective study in Korea

Journal of Clinical Oncology

Volumn 29, Issue 12, 2011, Pages 1592-1598

  Kitahara, Cari M ^a,b,c,d,e   De González, Amy Berrington ^a,b,c,d,e   Freedman, Neal D ^a,b,c,d,e   Huxley, Rachel ^a,b,c,d,e   Mok, Yejin ^a,b,c,d,e   Jee, Sun Ha ^a,b,c,d,e   Samet, Jonathan M ^a,b,c,d,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COLON CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HAZARD RATIO; HUMAN; KIDNEY CANCER; KOREA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHOLESTEROL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79955040537     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.5200     Document Type: Article

References (39)

1. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet 360:7-22, 2002
2. Huxley R, Lewington S, Clarke R: Cholesterol, coronary heart disease and stroke: A review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med 2:315-323, 2002
3. Toner CD, Davis CD, Milner JA: The vitamin D and cancer conundrum: Aiming at a moving target. J Am Diet Assoc 110:1492-1500, 2010
4. Eliassen AH, Hankinson SE: Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: Prospective studies. Adv Exp Med Biol 630:148-165, 2008
5. Crawford ED: Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 73:S4-S10, 2009 (suppl 5)
6. Knekt P, Reunanen A, Aromaa A, et al: Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol 41:519-530, 1988
7. Schatzkin A, Hoover RN, Taylor PR, et al: Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 48:452-458, 1988 (Pubitemid 18045786)
8. Törnberg SA, Holm LE, Carstensen JM, et al: Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst 81:1917-1921, 1989 (Pubitemid 20026079)
9. Strasak AM, Pfeiffer RM, Brant LJ, et al: Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: A prospective 19-year follow-up study. Ann Oncol 20:1113-1120, 2009
10. Iso H, Ikeda A, Inoue M, et al: Serum cholesterol levels in relation to the incidence of cancer: The JPHC study cohorts. Int J Cancer 125:2679-2686, 2009
11. Ahn J, Lim U, Weinstein SJ, et al: Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18:2814-2821, 2009
12. Kritchevsky SB, Kritchevsky D: Serum cholesterol and cancer risk: An epidemiologic perspective. Annu Rev Nutr 12:391-416, 1992
13. Kritchevsky SB, Wilcosky TC, Morris DL, et al: Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res 51:3198-3203, 1991
14. Törnberg SA, Carstensen JM, Holm LE: Risk of stomach cancer in association with serum cholesterol and beta-lipoprotein. Acta Oncol 27:39-42, 1988
15. Asano K, Kubo M, Yonemoto K, et al: Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: The Hisayama study. Int J Cancer 122:909-914, 2008
16. Törnberg SA, Holm LE, Carstensen JM: Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 27:31-37, 1988
17. Vatten LJ, Foss OP: Total serum cholesterol and triglycerides and risk of breast cancer: A prospective study of 24,329 Norwegian women. Cancer Res 50:2341-2346, 1990 (Pubitemid 20134492)
18. Platz EA, Clinton SK, Giovannucci E: Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer 123:1693-1698, 2008
19. Mondul AM, Clipp SL, Helzlsouer KJ, et al: Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control 21:61-68, 2010
20. Platz EA, Till C, Goodman PJ, et al: Men with low serum cholesterol have a lower risk of highgrade prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 18:2807-2813, 2009
21. Park SK, Sakoda LC, Kang D, et al: Rising prostate cancer rates in South Korea. Prostate 66: 1285-1291, 2006 (Pubitemid 44384305)
22. Berrington de Gonzalez A, Yun JE, Lee SY, et al: Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 17:359-364, 2008
23. Chen Z, Keech A, Collins R, et al: Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. BMJ 306:890-894, 1993 (Pubitemid 23093281)
24. Cicognani C, Malavolti M, Morselli-Labate AM, et al: Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 157:792-796, 1997 (Pubitemid 27164455)
25. Hiatt RA, Fireman BH: Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 39:861-870, 1986 (Pubitemid 17229983)
26. Chyou PH, Nomura AM, Stemmermann GN, et al: Prospective study of serum cholesterol and sitespecific cancers. J Clin Epidemiol 45:287-292, 1992
27. Platz EA: Does statin use affect the risk of developing prostate cancer? Nat Clin Pract Urol 6:70-71, 2009
28. Törnberg SA, Holm LE, Carstensen JM, et al: Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med 315:1629-1633, 1986 (Pubitemid 17052894)
29. Høyer AP, Engholm G: Serum lipids and breast cancer risk: A cohort study of 5,207 Danish women. Cancer Causes Control 3:403-408, 1992
30. Eliassen AH, Colditz GA, Rosner B, et al: Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 165:2264-2271, 2005 (Pubitemid 41549923)
31. Gaard M, Tretli S, Urdal P: Risk of breast cancer in relation to blood lipids: A prospective study of 31,209 Norwegian women. Cancer Causes Control 5:501-509, 1994 (Pubitemid 24335712)
32. Kaye JA, Meier CR, Walker AM, et al: Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer 86:1436-1439, 2002 (Pubitemid 34548066)
33. Ha M, Sung J, Song YM: Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control 20: 1055-1060, 2009
34. Wu H, Jiang H, Lu D, et al: Effect of simvastatin on glioma cell proliferation, migration, and apoptosis. Neurosurgery 65:1087-1096, 2009
35. World Cancer Research Fund: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC, World Cancer Research Fund and American Institute for Cancer Research, 2007
36. Shin HR: Epidemiology of hepatitis C virus in Korea. Intervirology 49:18-22, 2006
37. Gonyeau MJ, Yuen DW: A clinical review of statins and cancer: Helpful or harmful? Pharmacotherapy 30:177-194, 2010
38. Heart Protection Study Collaborative Group: The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: A randomized placebocontrolled trial [ISRCTN48489393]. BMC Med 3:6, 2005
39. Carroll MD, Lacher DA, Sorlie PD, et al: Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294:1773-1781, 2005 (Pubitemid 41434623)